Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate GoodRx Holdings, Inc. before investing.

In this article, we go over a few key elements for understanding GoodRx Holdings, Inc.’s stock price such as:

• GoodRx Holdings, Inc.’s current stock price and volume
• Why GoodRx Holdings, Inc.’s stock price changed recently
• Upgrades and downgrades for GDRX from analysts
• GDRX’s stock price momentum as measured by its relative strength

About GoodRx Holdings, Inc. (GDRX)

Before we jump into GoodRx Holdings, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Want to learn more about GoodRx Holdings, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about GoodRx Holdings, Inc..

GoodRx Holdings, Inc.’s Stock Price as of Market Close

As of December 10, 2025, 12:17 PM, CST, GoodRx Holdings, Inc.’s stock price was $2.765.

GoodRx Holdings, Inc. is up 2.41% from its previous closing price of $2.700.

During the last market session, GoodRx Holdings, Inc.’s stock traded between $2.680 and $2.790. Currently, there are approximately 346.78 million shares outstanding for GoodRx Holdings, Inc..

GoodRx Holdings, Inc.’s price-earnings (P/E) ratio is currently at 31.6, which is low compared to the Health Care Technology industry median of 43.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

GoodRx Holdings, Inc. Stock Price History

GoodRx Holdings, Inc.’s (GDRX) price is currently down 1.6% so far this month.

During the month of December, GoodRx Holdings, Inc.’s stock price has reached a high of $2.820 and a low of $2.615.

Over the last year, GoodRx Holdings, Inc. has hit prices as high as $5.810 and as low as $2.610. Year to date, GoodRx Holdings, Inc.’s stock is down 40.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused GoodRx Holdings, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 09, 2025, there were 7 analysts who downgraded GoodRx Holdings, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate GoodRx Holdings, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on GoodRx Holdings, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

GoodRx Holdings, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about GoodRx Holdings, Inc. (GDRX) by visiting AAII Stock Evaluator.

Relative Price Strength of GoodRx Holdings, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 09, 2025, GoodRx Holdings, Inc. has a weighted four-quarter relative price strength of -19.40%, which translates to a Momentum Score of 10 and is considered to be Very Weak.

Want to learn more about how GoodRx Holdings, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

GoodRx Holdings, Inc. Stock Price: Bottom Line

As of December 10, 2025, GoodRx Holdings, Inc.’s stock price is $2.765, which is up 2.41% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like GoodRx Holdings, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.